News / Events

One day in advance of the 24th EHA congress in Amsterdam, The Netherlands, we have had the opportunity to host our fifth HORIZON 2020 MMpredict consortium meeting. During this interactive session valuable input was exchanged amongst the project partners. We would like...

The Horizon 2020 MMpredict initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx B.V., the Department of Haematology of the Erasmus University Medical Centre Rotterdam (Erasmus MC), the Department of Onco-Haematology of...

We are happy to announce a subsequent milestone in the Horizon2020 project: All patient samples are analyzed at the SkylineDx lab

The MMpredict consortium has reached a new milestone in this project by completing the recruitment of the patient samples required in this project. With more than 800 myeloma samples recruited, the project team meets its aimed target population. The current efforts...

During the 23th EHA congress in Stockholm, Sweden, we have had the opportunity to host our fourth HORIZON 2020 project team meeting. We had an interactive session in which we discussed the project progress and short term future goals. The meeting was finalized by...

This month we celebrate the two-year anniversary of our Multiple Myeloma Horizon 2020 research project. Within this period we have made considerable progress towards our central goal of developing a personalized medicine tool that is capable of predicting the most...

The Multiple Myeloma horizon 2020 (MMh2020) initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx B.V., the Department of Haematology of the Erasmus University Medical Centre Rotterdam (Erasmus MC), the Department of...

Myeloma Patients Europe (MPE) is running a survey for European myeloma patients to understand their quality of life and how this is impacted by treatment side-effects.   To gain knowledge about the current Multiple Myeloma (MM) disease situation in Europe, we ask...

The Multiple Myeloma horizon 2020 (MMh2020) initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx B.V., the Department of Haematology of the Erasmus University Medical Center Rotterdam (Erasmus MC), the Department of...

At our third HORIZON 2020 project team meeting we welcomed all consortium partners at the SkylineDx headquarters in Rotterdam. During this successful assembly, a detailed overview of the currently included study cohort was given and the MPE presented their developed...